Eye Health

Newest Eye Health Information

5 Best Peptides for Diabetic Retinopathy

Five peptides come up repeatedly when people discuss diabetic retinopathy: GLP-1 receptor agonists are the most widely used peptide-class drugs among diabetic patients and carry the deepest human trial record, Luminate (risuteganib) and cibinetide have both advanced into clinical trials with real retinal outcome data, Visoluten is a peptide bioregulator with older human study data that a community of users reaches for specifically, and BPC-157 appears in community conversations on the basis of its broad vascular and anti-inflammatory properties. These five are numbered by how prominently each appears in research and real-world discussion, not ranked as a recommendation of one over another. No peptide is currently FDA-approved as a standalone treatment for diabetic retinopathy, and the right path for any individual depends on their clinical history and what they build with their care team or the MyPeptidePal app.

Eye Health 9 min read

7 Best Peptides for Retinal Health

People pursuing peptide support for retinal health are navigating a genuinely wide field, from clinically studied pharmaceutical candidates to community-used bioregulators with thin Western trial data. This guide covers seven compounds that people actually use or are actively discussing for retinal protection, photoreceptor preservation, and conditions including age-related macular degeneration, diabetic retinopathy, and retinitis pigmentosa. They are ordered by how prominently each appears in research and real-world use, not ranked as recommendations, because the right compound depends on your specific condition and the personalized plan you build with the app. The evidence picture varies dramatically across these seven: one has published human efficacy data showing meaningful visual improvement, one has completed Phase I and II trials, and others rest on preclinical animal work or community-reported experience. That range is the honest state of the field, and every entry below states it plainly.

Eye Health 12 min read

6 Best Peptides for Dry Eyes

People researching peptide options for dry eyes are looking at a genuinely active field, with six compounds that appear consistently across clinical pipelines, ophthalmology journals, and community protocols. The evidence ranges widely: Thymosin Beta-4 has completed Phase 2 randomized trials with statistically significant results, while Visoluten is used in community ocular health stacks with no dry-eye-specific clinical data. This guide covers each compound in order of how prominently it appears in research and real-world use for this goal, not as a ranking of one over another, because the right choice depends on the type of dry eye involved and what a practitioner helps you build.

Eye Health 12 min read

5 Best Peptides for Cataracts

When people look into peptides for cataracts, they are working in one of the narrowest evidence fields in all of peptide research. Only one compound, N-Acetylcarnosine, has published human clinical trial data for cataract-specific outcomes. A small number of others, including the peptide bioregulator Visoluten and several compounds currently confined to animal studies, round out what people are actually using or actively watching. This guide covers each of them honestly: what they are, how they are used for this goal, and exactly how strong or thin the evidence behind each one really is. The compounds are ordered by how prominently they appear in research and real-world use, not ranked as recommendations for any individual. Surgery remains the only proven treatment for established cataracts; what peptides offer at best is a preventive or progression-slowing role, and this article explains what that looks like in practice.

Eye Health 10 min read

6 Best Peptides for Glaucoma

Glaucoma research has surfaced a small but growing set of peptides that people use or actively discuss for two overlapping goals: lowering intraocular pressure and protecting the retinal ganglion cells that standard pressure-lowering drops cannot save on their own. As of 2026, no peptide has received FDA or EMA approval specifically for glaucoma, so the field spans FDA-approved compounds used off-label, Eastern European clinical preparations with limited Western study, and research-only candidates with strong preclinical signals but no human ocular data yet. This guide covers six compounds people actually reach for, ordered by how prominently each appears in research and documented real-world use, not as a ranking of one over another. The right choice depends on your specific situation, and the MyPeptidePal app is built to turn that map into a personalized plan.

Eye Health 11 min read

7 Best Peptides for Macular Degeneration

Macular degeneration sits at one of the most active frontiers in peptide research, with a field that spans FDA-approved injections, compounds in active human trials, and community-discussed options whose evidence is largely experiential. This guide covers the peptides people are actually using and talking about for AMD, from clinically studied options like Elamipretide and Risuteganib to less-validated but widely discussed compounds like Visoluten and BPC-157. The seven entries are ordered by how prominently each compound appears in research and documented real-world use, not as a recommendation of one over another, and the honest state of the evidence is described for each.

Eye Health 10 min read

7 Best Peptides for Eye Health

Peptide research for eye health covers a wider and more active field than most people expect, with several compounds now in human clinical trials for conditions like age-related macular degeneration and dry eye, alongside a separate group of well-known peptides including BPC-157, Epithalon, and GHK-Cu that biohackers use off-label for retinal support and visual function. This guide covers seven compounds people are using or actively discussing for eye health, from the most clinically advanced to the most community-driven, with an honest account of where the evidence stands for each. The compounds are ordered by how prominently each appears in published research and real-world use, not ranked as recommendations, and the right choice for any individual depends on their specific condition, situation, and goals.

Eye Health 11 min read

dont Spend six hours researching every peptide.

About MyPeptidePal

MyPeptidePal is the world's largest peptide knowledge base and your personal AI peptide expert in one. Trained on every published study and over 10,000 protocols, it gets smarter every day, learning from new research and a community actively running and tracking their own. Build a personalized protocol in 60 seconds, get dosing math you can trust, find vetted suppliers, set auto-pilot reminders, and get straight answers on peptides, health, fitness, and longevity, all in one place. Try for FREE Here, no credit card required.